Archive for 2008/03


Can EU Stop TB? ECDC Sets Out Plan Of Action As Report Shows Nearly 90,000 Cases Annually In Union

Tuberculosis (TB) has been a treatable disease since the 1950s. Why then are tens of thousands of people getting TB each year in the EU? In the run up to World TB Day (24 March), the EU funded EuroTB network has released data showing that nearly 90,000 TB cases were reported in the EU in 2006. The Stockholm based European Centre for Disease Prevention and Control (ECDC) has published an action plan to better control - and ultimately eliminate - TB in the EU.
(more...)


03/25/2008 | Respiratory & Asthma | Trackback | Comments Off

Statement From Kent Hill, USAID Assistant Administrator For Global Health, On The Observance Of World Tuberculosis Day 2008

The following are remarks by Kent Hill, USAID Assistant Administrator for Global Health, on the observance of World Tuberculosis Day 2008: Although a cure for Tuberculosis (TB) has existed for more than half a century, TB remains one of three leading causes of death worldwide due to infectious disease. TB kills approximately 1.
(more...)


03/25/2008 | Respiratory & Asthma | Trackback | Comments Off

MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial For Its Pediatric Asthma Product Candidate

MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) announced that in a pharmacokinetic clinical trial Unit Dose Budesonide (UDB) demonstrated lower systemic drug exposure when compared to the currently marketed conventional nebulized budesonide. UDB is MAP Pharmaceuticals' proprietary nebulized formulation of budesonide, currently in Phase 3 clinical development, for the potential treatment of pediatric asthma.
(more...)


03/25/2008 | Respiratory & Asthma | Trackback | Comments Off

On World TB Day, American Lung Association Seeking Redoubled Efforts To Protect Public Health

Initially founded to combat tuberculosis (TB) more than a century ago, the American Lung Association today urges Congress to act decisively to finally eliminate TB in America. The Comprehensive TB Elimination Act, S. 1551/HR 1532, now pending in the Congress, would propel the U.S. Public Health Service's efforts and lead international work to eradicate the infection globally.
(more...)


03/24/2008 | Respiratory & Asthma | Trackback | Comments Off

EMEA Recommends New Contraindication For Velcade (bortezomib), Europe

The European Medicines Agency (EMEA) has recommended that Velcade (bortezomib) should not be used in patients with certain severe pulmonary or heart problems (acute diffuse infiltrative pulmonary and pericardial disease). Velcade is used to treat progressive multiple myeloma in patients who have failed to respond to at least one other treatment and who have already undergone or are unsuitable for bone marrow transplantation.
(more...)


03/24/2008 | Respiratory & Asthma | Trackback | Comments Off

Dr. Hugh A. Sampson Elected President Of The American Academy Of Allergy, Asthma & Immunology (AAAAI)

Hugh A. Sampson, MD, FAAAAI, was elected President of the American Academy of Allergy, Asthma & Immunology (AAAAI) during its 2008 Annual Meeting in Philadelphia. He will serve as President through March 2009. The AAAAI is the largest professional medical specialty organization in the United States representing allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic disease.
(more...)


03/24/2008 | Respiratory & Asthma | Trackback | Comments Off

Stopping A Deadly Killer: Pitt Receives $11.4 Million Gates Foundation Grant For Tuberculosis Research

To develop new strategies to control tuberculosis (TB), a contagious disease that infects one-third of the world's population and kills almost two million people every year, the University of Pittsburgh Center for Vaccine Research has received an $11.4 million grant from the Bill & Melinda Gates Foundation.
(more...)


03/22/2008 | Respiratory & Asthma | Trackback | Comments Off

Methamphetamine Use Associated With Pulmonary Arterial Hypertension In Patients With Previously Unknown Risk Factors

The Pulmonary Hypertension Association (PHA), in conjunction with leading pulmonary hypertension specialists, announced the launch of an educational campaign to raise awareness of the association between pulmonary arterial hypertension (PAH) and stimulant use, particularly methamphetamine use.
(more...)


03/22/2008 | Respiratory & Asthma | Trackback | Comments Off

Computerized Program Helps Teens Quit Smoking

A cigarette hanging from a teenager's mouth is a sight that makes most adults cringe. With 22% of high school students and 10% of middle school children smoking in America, the habit is considered an epidemic, according to the Centers for Disease Control and Prevention (CDC). However, a recent article in Pediatric Nursing journal shows that there are effective quitting programs available that offer hope. Deborah J.
(more...)


03/21/2008 | Respiratory & Asthma | Trackback | Comments Off

Asthma Risk In Women Reduced By Aspirin

A study published in the journal Thorax found thatwomen who take a small dose ofaspirin on alternate days can reduce the risk of developing asthma.Asthma is a condition concerning the respiratory system in which theairway constricts, becomes inflamed, and is lined with copious amountsof mucous.
(more...)


03/21/2008 | Respiratory & Asthma | Trackback | Comments Off

« Previous Entries
Next Entries »

© 2006 MBGJ.Org Limited Trading as Natural-Remedies-Clinic

All rights reserved - Designated trademarks and brands are the property of their respective owners

Natural Remedies Clinic - Main Site


Page Sponsors

- -

>-- Top of Page --<